Daiwa Securities Group
FUSN

Daiwa Securities Group’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Daiwa Securities Group’s Portfolio FUSN Stock Details FUSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-268
Closed -$6K – 1380
2024
Q1 		$6K Buy
+268
New +$3.21K ﹤0.01% 1198
2021
Q4 		– Sell
-78
Closed -$1K – 1463
2021
Q3 		$1K Hold
78
– – ﹤0.01% 1292
2021
Q2 		$1K Hold
78
– – ﹤0.01% 1229
2021
Q1 		$1K Hold
78
– – ﹤0.01% 1240
2020
Q4 		$1K Buy
+78
New +$980 ﹤0.01% 1222

Daiwa Securities Group's FUSN Position: Q2 2024 in Review

Daiwa Securities Group sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 268 shares — an estimated $6K sold.

Daiwa Securities Group first reported a position in FUSN in Q4 2020 and held it in 5 quarters. The position peaked at $6K in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

  • Daiwa Securities Group reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
  • Daiwa Securities Group sold 268 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $6K.
  • Daiwa Securities Group first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q4 2020 and held it in 5 quarters.
  • Daiwa Securities Group's Fusion Pharmaceuticals Inc. Common Shares position peaked at $6K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Daiwa Securities Group's 13F filing for Q2 2024, filed 7 Aug 2024.